Preclinical evaluation of discorhabdin in antiangiogenic and antitumor models (Marine Drugs, 2018)

(untitled) - Harris, E; Strope, J; Shaunna, B; Huang, P; Goey, A; Cook, K; Schofield, C; Chau, C; Cadelis, M; Copp, B; Gastafson, K; Figg, W